Erie, CO, United States of America

Nicole M Littmann

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Japan Tobacco Inc.. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicole M Littmann. Retrieved from https://idiyas.com/inventor/nicole-m-littmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicole M Littmann: Innovator in Pharmaceutical Compounds

Introduction: Nicole M Littmann is a prominent inventor based in Erie, Colorado, known for her contributions to the field of pharmaceutical compounds. She has developed innovative solutions aimed at addressing significant health issues, particularly in the realm of arthritis treatment.

Latest Patents: Nicole holds a patent for "Cyclopropane compounds and pharmaceutical use thereof." This invention provides a compound with aggrecanase inhibitory activity and MMP-13 inhibitory activity, making it useful as a therapeutic agent for osteoarthritis and rheumatoid arthritis. The patent details a cyclopropane compound with specific structural formulas, highlighting its potential as a treatment option.

Career Highlights: Nicole is currently employed at Japan Tobacco Inc., where she continues to advance her research and development efforts. Her work focuses on creating effective pharmaceutical agents that can significantly improve patient outcomes.

Collaborations: Nicole has collaborated with notable colleagues, including Takashi Inaba and Julia Haas, to further her research initiatives and enhance the impact of her inventions.

Conclusion: Nicole M Littmann's innovative work in pharmaceutical compounds exemplifies her commitment to improving healthcare solutions. Her contributions are paving the way for new treatments that can benefit many individuals suffering from arthritis-related conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…